The Mesenchymal Stem Cells in Multiple Sclerosis (MSCIMS) Trial protocol and baseline cohort characteristics: an open-label pre-test : post-test study with blinded outcome assessments.

Connick, P; Kolappan, M; Patani, R; Scott, MA; Crawley, C; He, XL; Richardson, K; Barber, K; Webber, DJ; Wheeler-Kingshott, CA; +11 more... Tozer, DJ; Samson, RS; Thomas, DL; Du, MQ; Luan, SL; Michell, AW; Altmann, DR; Thompson, AJ; Miller, DH; Compston, A; Chandran, S; (2011) The Mesenchymal Stem Cells in Multiple Sclerosis (MSCIMS) Trial protocol and baseline cohort characteristics: an open-label pre-test : post-test study with blinded outcome assessments. Trials, 12 (1). p. 62. ISSN 1745-6215 DOI: https://doi.org/10.1186/1745-6215-12-62

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1186/1745-6215-12-62

Abstract

Share

Download

Filename: 1745-6215-12-62.pdf

Licence: Creative Commons: Attribution 3.0

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar